Wealth Enhancement Advisory Services
DFTX

Wealth Enhancement Advisory Services’s Definium Therapeutics DFTX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Buy
+7,952
New +$197K ﹤0.01% 2979
2026
Q1 		– Sell
-13,718
Closed -$185K – 3773
2025
Q4 		$185K Buy
13,718
+366
+3% +$4.53K ﹤0.01% 3294
2025
Q3 		$160K Sell
13,352
-84
-0.6% -$783 ﹤0.01% 3214
2025
Q2 		$96.3K Sell
13,436
-102
-0.8% -$671 ﹤0.01% 3142
2025
Q1 		$79.2K Sell
13,538
-12
-0.1% -$86 ﹤0.01% 2802
2024
Q4 		$94.3K Buy
13,550
+3,350
+33% +$23K ﹤0.01% 2810
2024
Q3 		$58K Buy
+10,200
New +$70.9K ﹤0.01% 2608

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Wealth Enhancement Advisory Services's DFTX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 7,952 shares worth $374K. The stake represents ﹤0.01% of the portfolio and ranks #2979 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in DFTX as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in DFTX in Q3 2024 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 7,952 shares of Definium Therapeutics worth $374K as of Q2 2026.
  • Definium Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2979 holding.
  • Wealth Enhancement Advisory Services first reported a position in Definium Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 17 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.